Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

"name": "GPT - Billboard - Slot Inline - Content - Labeled - No Desktop", "component": "23668565", "insertPoint": "2", ...

India has a massive local community and a population with high levels of disposable income,” he ... Besides, we have a portfolio of brands from economy to mid-scale to luxury to lifestyle ...

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

Phil Brooks, a Black American, patented a disposable syringe design on April 9, 1974, contributing to safer healthcare. While not the inventor of the hypodermic syringe, his work added to the history ...

The Managing Director and Chief Executive Officer (CEO)of Transgreen Nigeria Limited, Cyprian Orakpo has called for the ban on importation of disposable syringes in Nigeria. He urged the Federal ...